Cargando…

The assessment of severe cutaneous adverse drug reactions

Severe cutaneous adverse drug reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalised exanthematous pustulosis. These eruptions are a type of delayed hypersensitivity reaction and can be life-threatening. The assessment of a severe cutaneous drug reaction require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Copaescu, Ana M, Trublano, Jason A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081939/ https://www.ncbi.nlm.nih.gov/pubmed/35592375 http://dx.doi.org/10.18773/austprescr.2022.010

Ejemplares similares

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
por: Mokhtari, Fatemeh, et al.
Publicado: (2014)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions
por: Nicholas, Rajam, et al.
Publicado: (2021)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions
por: Beniwal, Ranjana, et al.
Publicado: (2019)

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
por: Gabriel, Joseph Gabriel, et al.
Publicado: (2017)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia
por: AlJasser, Mohammed I.
Publicado: (2023)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
por: Hoosen, Koraisha, et al.
Publicado: (2019)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later
por: Copaescu, Ana M., et al.
Publicado: (2022)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
por: Ambe, Kaori, et al.
Publicado: (2021)

An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese
por: Jiang, Menglin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8km72r0jvap1fud73tb8s6rqv